Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology

Kidney International

Volumn 50, Issue 1, 1996, Pages 282-289

  Tan, Si Yen ^b   Irish, Ashley ^b   Winearls, Christopher G ^b   Brown, Edwina A ^b   Gower, Peter E ^b   Clutterbuck, Elaine J ^b   Madhoo, Sheril ^b   Lavender, J Peter ^b   Pepys, Mark B ^b   Hawkins, Philip N ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BONE CYST; BONE RADIOGRAPHY; CLINICAL ARTICLE; DIALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 10144252427     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.313     Document Type: Article

References (32)

1. VAN YPERSELE DE STRIHOU C, JADOUL M, MALGHEM J, MALDAGUE B, JAMART J, FOR THE WORKING PARTY ON DIALYSIS AMYLOIDOSIS: Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 39:1012-1019, 1991
2. ZINGRAFF J, DRUEKE T: Can the nephrologist prevent dialysis-related amyloidosis? Am J Kidney Dis 18:1-11, 1991
3. KOCH KM: Dialysis-related amyloidosis |clinical conference|. Kidney Int 41:1416-1429, 1992
4. CAMPISTOL JM, SOLE M, MUNOZ GJ, LOPEZ PJ, REVERT L: Systemic involvement of dialysis-amyloidosis. Am J Nephrol 10:389-396, 1990
5. 2-microglobulin. Biochem Biophys Res Commun 129:701-706, 1985
6. PEPYS MB: Amyloidosis, in Samter's Immunological Diseases (5th ed), edited by FRANK MM, AUSTEN KF, CLAMAN HN, UNANUE ER, Boston, Little, Brown and Company, 1994, pp 637-655
7. JADOUL M, MALGHEM J, PIRSON Y, MALDAGUE B, VAN YPERSELE DE STRIHOU C: Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy. Clin Nephrol 32:194-197, 1989
8. 123Habeled serum amyloid P component. N Engl J Med 323:508-513, 1990
9. HAWKINS PN, WOOTTON R, PEPYS MB: Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J Clin Invest 86:1862-1869, 1990
10. HAWKINS PN, RICHARDSON S, MACSWEENEY JE, KING AD, VIGUSHIN DM, LAVENDER JP, PEPYS MB: Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Q J Med 86:365-374, 1993
11. HAWKINS PN, RICHARDSON S, VIGUSHIN DM, DAVID J, KELSEY CR, GRAY RES, HALL MA, Woo P, LAVENDER JP, PEPYS MB: Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum 36:842-851, 1993
12. HOLMGREN G, ERICZON B-G, GROTH C-G, STEEN L, SUHR O, ANDERSEN O, WALLIN BG, SEYMOUR A, RICHARDSON S, HAWKINS PN, PEPYS MB: Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341:1113-1116, 1993
13. HAWKINS PN, VIGUSHIN DM, RICHARDSON S, SEYMOUR A, PEPYS MB: Evaluation of 100 cases of systemic AL amyloidosis by serum amyloid P component (SAP) scintigraphy, in Amyloid and Amyloidosis 1993, edited by KISILEVSKY R, BENSON MD, FRANGIONE B, GAULDIE J, MUCKLE TJ, YOUNG ID, Pearl River, New York, Parthenon Publishing, 1994, pp 209-211
14. HALL R, HAWKINS PN: Cardiac transplantation for AL amyloidosis: A personal account. Br Med J 309:1135-1137, 1994
15. 131I-serum amyloid P component. Lancet 338:335-339, 1991
16. HAWKINS PN, MYERS MJ, LAVENDER JP, PEPYS MB: Diagnostic radionuclide imaging of amyloid: Biological targeting by circulating human serum amyloid P component. Lancet i:1413-1418, 1988
17. PUCHTLER H, SWEAT F, LEVINE M: On the binding of Congo red by amyloid. J Histochem Cytochem 10:355-364, 1962
18. PEPYS MB: Amyloid P component and the diagnosis of amyloidosis. J Intern Med 232:519-521, 1992
19. PEPYS MB, DASH AC, MARKHAM RE, THOMAS HC, WILLIAMS BD, PETRIE A: Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol 32:119-124, 1978
20. NELSON SR, TENNENT GA, SETHI D, GOWER PE, BALLARDIE FW, AMATAYAKUL-CHANTLER S, PEPYS MB: Serum amyloid P component in chronic renal failure and dialysis, Clin Chim Acta 200:191-200, 1991
21. 2-microglobulin a mediator of bone disease? (Editorial Review) Kidney Int 47:1-6, 1995
22. 2M amyloidosis in hemodialysis: A prospective post-mortem study. (abstract) Nephrol Dial Transplant 9:1013-1014, 1994
23. BARDIN T: Low-dose prednisone in dialysis-related amyloid arthropathy. Rev Rhum [Engl Ed] 61(Suppl):97S-100S, 1994
24. CAMPISTOL JM, PONZ E, MUNOZ GJ, OPPENHEIMER F, RICARD MJ, VILARDELL J, ANDREU J: Renal transplantation for dialysis amyloidosis. Transplant Proc 24:118-119, 1992
25. NELSON SR, SHARPSTONE P, KINGSWOOD JC: Does dialysis-associated amyloidosis resolve after transplantation? Nephrol Dial Transplant 8:369-370, 1993
26. 123I-labeled serum amyloid P component. J Exp Med 167:903-913, 1988
27. VIGUSHIN DM, PEPYS MB, HAWKINS PN: Comparison of histology with SAP scintigraphy for evaluation of amyloidosis, in Amyloid and Amyloidosis 1993, edited by KISILEVSKY R, BENSON MD, FRANGIONE B, GAULDIE J, MUCKLE TJ, YOUNG ID, Pearl River, New York. Parthenon Publishing, 1994, pp 685-687
28. HAWKINS PN: Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin Sci 87:289-295, 1994
29. HAWKINS PN, PEPYS MB: Imaging amyloidosis with radiolabelled SAP. Eur J Nucl Med 22:595-599, 1995
30. TAN SY, PEPYS MB, HAWKINS PN: Treatment of amyloidosis. Am J Kidney Dis 26:267-285, 1995
31. SAÏLE R, DEVEAUX M, HACHULLA E, DESCAMPS J, DUQUESNOY B, MARCHANDISE X: Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis. Eur J Nucl Med 20:130-137, 1993
32. 99mTc-labelled serum amyloid P component, in Amyloid and Amyloidosis 1993, edited by KISILEVSKY R, BENSON MD, FRANGIONE B, GAULDIE J, MUCKLE TJ, YOUNG ID, Pearl River. New York, Parthenon Publishing, 1994. pp 682-684